Transitional Drugs 7
Details
| Contract Title: | Transitional Drugs 7 |
| Published Date: | Apr 12, 2026 |
| Notice Type: | Notice (ContractNotice) |
| Value Banding: | High Value |
| Delivery Point: | United Kingdom |
Description:
The provision of Drugs which have lost or are shortly to lose exclusivity, namely Eculizumab; Icatibant; Nintedanib; Omalizumab; Tocilizumab...